Credit Suisse Starts Akebia Therapeutics (AKBA) at Outperform

Go back to Credit Suisse Starts Akebia Therapeutics (AKBA) at Outperform
AKEBIA THERAPEUTICS (NASDAQ: AKBA) Delayed: 0.89 --0 (-0%)
Previous Close $0.89    52 Week High $13.20 
Open $0.89    52 Week Low $7.00 
Day High $0.89    P/E N/A 
Day Low $0.89    EPS $0.00 
Volume 7,216